Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2009 1
2010 1
2011 5
2012 6
2013 7
2014 5
2015 11
2016 5
2017 4
2018 9
2019 6
2020 7
2021 9
2022 5
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

72 results

Results by year

Filters applied: . Clear all
Page 1
Tachyphylaxis and reproducibility of desmopressin response in perioperative persons with nonsevere hemophilia A: implications for clinical practice.
Romano LGR, Schütte LM, van Hest RM, Meijer K, Laros-van Gorkom BAP, Nieuwenhuizen L, Eikenboom J, Heubel-Moenen FCJI, Uitslager N, Coppens M, Fijnvandraat K, Driessens MHE, Polinder S, Cnossen MH, Leebeek FWG, Mathôt RAA, Kruip MJHA; DAVID and SYMPHONY Consortium. Romano LGR, et al. Among authors: laros van gorkom bap. Res Pract Thromb Haemost. 2024 Mar 5;8(3):102367. doi: 10.1016/j.rpth.2024.102367. eCollection 2024 Mar. Res Pract Thromb Haemost. 2024. PMID: 38660455 Free PMC article.
Peri-operative desmopressin combined with pharmacokinetic-guided factor VIII concentrate in non-severe haemophilia A patients.
Romano LGR, Schütte LM, van Hest RM, Meijer K, Laros-van Gorkom BAP, Nieuwenhuizen L, Eikenboom J, Heubel-Moenen FCJI, Uitslager N, Coppens M, Fijnvandraat K, Driessens MHE, Polinder S, Cnossen MH, Leebeek FWG, Mathôt RAA, Kruip MJHA;  the DAVID and SYMPHONY Consortium. Romano LGR, et al. Among authors: laros van gorkom bap. Haemophilia. 2024 Mar;30(2):355-366. doi: 10.1111/hae.14946. Epub 2024 Feb 11. Haemophilia. 2024. PMID: 38343113
Transition readiness among adolescents and young adults with haemophilia in the Netherlands: Nationwide questionnaire study.
Brands MR, Janssen EAM, Cnossen MH, Smit C, van Vulpen LFD, van der Valk PR, Eikenboom J, Heubel-Moenen FCJI, Hooimeijer L, Ypma P, Nieuwenhuizen L, Coppens M, Schols SEM, Laros-van Gorkom BAP, Leebeek FWG, Driessens MHE, Rosendaal FR, van der Bom JG, Fijnvandraat K, Gouw SC. Brands MR, et al. Among authors: laros van gorkom bap. Haemophilia. 2023 Sep;29(5):1191-1201. doi: 10.1111/hae.14834. Epub 2023 Aug 21. Haemophilia. 2023. PMID: 37602825
Desmopressin testing in von Willebrand disease: Lowering the burden.
Heijdra JM, Atiq F, Al Arashi W, Kieboom Q, Wuijster E, Meijer K, Kruip MJHA, Leebeek FWG, Cnossen MH; OPTI‐CLOT Study Group. Heijdra JM, et al. Res Pract Thromb Haemost. 2022 Sep 26;6(6):e12784. doi: 10.1002/rth2.12784. eCollection 2022 Aug. Res Pract Thromb Haemost. 2022. PMID: 36186107 Free PMC article.
Importance of Genotyping in von Willebrand Disease to Elucidate Pathogenic Mechanisms and Variability in Phenotype.
Atiq F, Boender J, van Heerde WL, Tellez Garcia JM, Schoormans SC, Krouwel S, Cnossen MH, Laros-van Gorkom BAP, de Meris J, Fijnvandraat K, van der Bom JG, Meijer K, van Galen KPM, Eikenboom J, Leebeek FWG. Atiq F, et al. Among authors: laros van gorkom bap. Hemasphere. 2022 May 11;6(6):e718. doi: 10.1097/HS9.0000000000000718. eCollection 2022 Jun. Hemasphere. 2022. PMID: 35747851 Free PMC article.
Fibrinolytic assays in bleeding of unknown cause: Improvement in diagnostic yield.
Valke LLFG, Meijer D, Nieuwenhuizen L, Laros-van Gorkom BAP, Blijlevens NMA, van Heerde WL, Schols SEM. Valke LLFG, et al. Among authors: laros van gorkom bap. Res Pract Thromb Haemost. 2022 Mar 15;6(2):e12681. doi: 10.1002/rth2.12681. eCollection 2022 Feb. Res Pract Thromb Haemost. 2022. PMID: 35316940 Free PMC article.
Combining factor VIII levels and thrombin/plasmin generation: A population pharmacokinetic-pharmacodynamic model for patients with haemophilia A.
Bukkems LH, Valke LLFG, Barteling W, Laros-van Gorkom BAP, Blijlevens NMA, Cnossen MH, van Heerde WL, Schols SEM, Mathôt RAA. Bukkems LH, et al. Among authors: laros van gorkom bap. Br J Clin Pharmacol. 2022 Jun;88(6):2757-2768. doi: 10.1111/bcp.15185. Epub 2022 Jan 15. Br J Clin Pharmacol. 2022. PMID: 34921439 Free PMC article.
Von Willebrand disease type 2M: Correlation between genotype and phenotype.
Maas DPMSM, Atiq F, Blijlevens NMA, Brons PPT, Krouwel S, Laros-van Gorkom BAP, Leebeek FWG, Nieuwenhuizen L, Schoormans SCM, Simons A, Meijer D, van Heerde WL, Schols SEM. Maas DPMSM, et al. Among authors: laros van gorkom bap. J Thromb Haemost. 2022 Feb;20(2):316-327. doi: 10.1111/jth.15586. Epub 2021 Nov 21. J Thromb Haemost. 2022. PMID: 34758185 Free PMC article.
Perioperative pharmacokinetic-guided factor VIII concentrate dosing in haemophilia (OPTI-CLOT trial): an open-label, multicentre, randomised, controlled trial.
van Moort I, Preijers T, Bukkems LH, Hazendonk HCAM, van der Bom JG, Laros-van Gorkom BAP, Beckers EAM, Nieuwenhuizen L, van der Meer FJM, Ypma P, Coppens M, Fijnvandraat K, Schutgens REG, Meijer K, Leebeek FWG, Mathôt RAA, Cnossen MH; OPTI-CLOT study group. van Moort I, et al. Among authors: laros van gorkom bap. Lancet Haematol. 2021 Jul;8(7):e492-e502. doi: 10.1016/S2352-3026(21)00135-6. Lancet Haematol. 2021. PMID: 34171280 Clinical Trial.
72 results